Monographie - Moxifloxacin

Laatste update :
29/10/2024

Moxifloxacin

Molecuulstructuur

Merknamen in verschillende landen

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

Actira	Luxemburg, Nederland, Spanje, Zweden
Avalox	Argentinië, Australië, België, Brazilië, Canada, Chili, Colombia, Denemarken, Duitsland, Ecuador, Finland, Hongarije, Ierland, Maleisië, Marokko, Mexico, Nederland, nieuw Zeeland, Peru, Roemenië, Saudi-Arabië, Turkije, USA, Venezuela, Verenigde Arabische Emiraten, Zweden
Axokine	Venezuela
Mahaflox	Indië
Mofelox	Turkije
Mofinacin	Roemenië
Moflaxa	Roemenië
Moksefen	Turkije
Moksilox	Turkije
Moxacin	Turkije
Moxifix	Turkije
Moxifloxin	België, Duitsland
Moxifloxina	Roemenië
Moxifloxino	Chili, Spanje
Muzdil	Spanje
Octegra	Nederland, Zweden
Pixiriv	Mexico
Praiva	Ecuador, Peru
Proflox	Luxemburg

Literatuur : Moxifloxacin

	type	publicatie
2017	Artikel	Barker B, Feddema S, Rusho WJ, Dengg R. Visual compatibility of vasopressin with other injectable drugs. Am J Health-Syst Pharm 2005 ; 62: 1969-1976.
2145	Artikel	Fernandez-Varon E, Marin P, Espuny A, Villamayor L, Escudero E, Carceles C. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36%® and Dianeal PD1 3.86%®). J Clin Pharm Ther 2006 ; 31: 641-643.
2231	Artikel	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2262	Artikel	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2269	Artikel	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3109	fabrikant	Moxifloxacine (Izilox®) -Notice information Bayer Schering Pharma 2010
3162	fabrikant	Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits Bayer HealthCare 2010
3249	Artikel	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
3385	Artikel	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3865	Artikel	Vicky M, Samit S, Jaymin P, Michael C T. Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Int J Pharm Compound 2016 ; 20, 3 : 236-238.
4650	fabrikant	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021
4758	Artikel	Schmidt J.P, Steppe M. Stability Study and Simultaneous Determination of Norepinephrine, Moxifloxacin, and Piperacillin + Tazobactam Mixtures Applied in Intensive Care Medicine . Curr Pharm Anal 2023 ; 19, 4: 307-316.

Mentions Légales